$2.98 Billion is the total value of HealthCor Management, L.P.'s 40 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BAX | Exit | BAXTER INTL INC | $0 | – | -65,610 | -100.0% | -0.14% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -150,000 | -100.0% | -0.47% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -327,064 | -100.0% | -0.97% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -500,000 | -100.0% | -1.00% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG COcall | $0 | – | -500,000 | -100.0% | -1.15% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCcall | $0 | – | -350,000 | -100.0% | -1.18% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -424,350 | -100.0% | -1.20% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -432,864 | -100.0% | -1.25% | – |
| MD | Exit | MEDNAX INC | $0 | – | -942,730 | -100.0% | -2.05% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -1,688,060 | -100.0% | -2.76% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -1,084,396 | -100.0% | -3.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.